Published in Stroke on February 01, 2007
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model. J Thromb Haemost (2011) 1.51
Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke (2009) 1.46
Blood-brain barrier breakdown and repair by Src after thrombin-induced injury. Ann Neurol (2010) 1.26
Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol (2012) 1.19
The relationship between hematoma iron content and perihematoma edema: an MRI study. Cerebrovasc Dis (2009) 1.09
(-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways. Ann Clin Transl Neurol (2014) 1.04
Proteinase-activated receptors in the nucleus of the solitary tract: evidence for glial-neural interactions in autonomic control of the stomach. J Neurosci (2009) 1.04
Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow Metab (2011) 1.02
Minocycline reduces intracerebral hemorrhage-induced brain injury. Neurol Res (2008) 1.02
Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage. Fluids Barriers CNS (2014) 1.00
Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med Chem (2010) 0.98
Alcoholism: a systemic proinflammatory condition. World J Gastroenterol (2014) 0.96
The pericyte: a forgotten cell type with important implications for Alzheimer's disease? Brain Pathol (2014) 0.96
Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc Dis (2010) 0.96
The complement cascade as a therapeutic target in intracerebral hemorrhage. Exp Neurol (2009) 0.94
Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke. Antioxid Redox Signal (2010) 0.94
Dynamic increase in extracellular ATP accelerates photoreceptor cell apoptosis via ligation of P2RX7 in subretinal hemorrhage. PLoS One (2013) 0.93
Hydrocephalus after intraventricular hemorrhage: the role of thrombin. J Cereb Blood Flow Metab (2013) 0.92
Elevation of high-mobility group protein box-1 in serum correlates with severity of acute intracerebral hemorrhage. Mediators Inflamm (2010) 0.92
Evaluation of brain iron content based on magnetic resonance imaging (MRI): comparison among phase value, R2* and magnitude signal intensity. PLoS One (2012) 0.92
Activation of c-Jun-N-terminal kinase in a rat model of intracerebral hemorrhage: the role of iron. Neurosci Res (2008) 0.90
Role of hemoglobin and iron in hydrocephalus after neonatal intraventricular hemorrhage. Neurosurgery (2014) 0.89
X-ray fluorescence analysis of long-term changes in the levels and distributions of trace elements in the rat brain following mechanical injury. J Biol Inorg Chem (2010) 0.87
Time course of upregulation of inflammatory mediators in the hemorrhagic brain in rats: correlation with brain edema. Neurochem Int (2010) 0.86
Inhibition of carbonic anhydrase reduces brain injury after intracerebral hemorrhage. Transl Stroke Res (2012) 0.86
Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage. J Neuroimmune Pharmacol (2015) 0.84
Brain injury after intracerebral hemorrhage in spontaneously hypertensive rats. J Neurosurg (2011) 0.84
Curcumin attenuates brain edema in mice with intracerebral hemorrhage through inhibition of AQP4 and AQP9 expression. Acta Pharmacol Sin (2015) 0.84
Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol (2013) 0.83
Iron-induced necrotic brain cell death in rats with different aerobic capacity. Transl Stroke Res (2015) 0.83
A rapid fluorescent method to quantify neuronal loss after experimental intracerebral hemorrhage. J Neurosci Methods (2013) 0.83
Neuroprotective effect of heme oxygenase-2 knockout in the blood injection model of intracerebral hemorrhage. BMC Res Notes (2014) 0.83
Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray? Alzheimers Dement (2011) 0.82
Astrocyte overexpression of heme oxygenase-1 improves outcome after intracerebral hemorrhage. Stroke (2015) 0.80
Novel organotypic in vitro slice culture model for intraventricular hemorrhage of premature infants. J Neurosci Res (2012) 0.80
Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor. BMC Neurosci (2015) 0.80
Intercellular cross-talk in intracerebral hemorrhage. Brain Res (2015) 0.79
Ferrous citrate up-regulates the NOS2 through nuclear translocation of NFκB induced by free radicals generation in mouse cerebral endothelial cells. PLoS One (2012) 0.79
TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage. J Clin Invest (2016) 0.79
Thrombin-induced microglial activation impairs hippocampal neurogenesis and spatial memory ability in mice. Behav Brain Funct (2015) 0.78
Stem cell therapy in intracerebral hemorrhage rat model. World J Stem Cells (2015) 0.78
Progressing haemorrhagic stroke: categories, causes, mechanisms and managements. J Neurol (2014) 0.78
Bilirubin and its oxidation products damage brain white matter. J Cereb Blood Flow Metab (2014) 0.78
Oral anticoagulant-associated intracerebral hemorrhage. J Neurol (2011) 0.77
Stages of the Inflammatory Response in Pathology and Tissue Repair after Intracerebral Hemorrhage. Semin Neurol (2016) 0.77
Thrombin: is it on a par with seizures and epilepsy? Epilepsy Curr (2008) 0.77
The relationship between the serum levels of ferritin and the radiological brain injury indices in patients with spontaneous intracerebral hemorrhage. Iran J Basic Med Sci (2014) 0.77
The Importance of Thrombin in Cerebral Injury and Disease. Int J Mol Sci (2016) 0.76
Neuro-regeneration therapy using human Muse cells is highly effective in a mouse intracerebral hemorrhage model. Exp Brain Res (2016) 0.76
Effects of human umbilical cord mesenchymal stem cell transplantation combined with minimally invasive hematoma aspiration on intracerebral hemorrhage in rats. Am J Transl Res (2015) 0.75
Gene expression profiles of patients with cerebral hematoma following spontaneous intracerebral hemorrhage. Mol Med Rep (2014) 0.75
Aging of cerebral white matter. Ageing Res Rev (2016) 0.75
Src Family Kinases in Brain Edema After Acute Brain Injury. Acta Neurochir Suppl (2016) 0.75
Secondary Hematoma Expansion and Perihemorrhagic Edema after Intracerebral Hemorrhage: From Bench Work to Practical Aspects. Front Neurol (2017) 0.75
Pretreatment of Mouse Neural Stem Cells with Carbon Monoxide-Releasing Molecule-2 Interferes with NF-κB p65 Signaling and Suppresses Iron Overload-Induced Apoptosis. Cell Mol Neurobiol (2016) 0.75
Preclinical Studies and Translational Applications of Intracerebral Hemorrhage. Biomed Res Int (2017) 0.75
Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol (2006) 6.06
Adjacent segment disease after lumbar or lumbosacral fusion: review of the literature. Spine (Phila Pa 1976) (2004) 4.75
Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke (2003) 2.71
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol (2012) 2.62
Behavioral tests after intracerebral hemorrhage in the rat. Stroke (2002) 2.46
Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab (2005) 2.45
Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg (2002) 2.40
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg (2004) 2.31
Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci (2003) 2.21
Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke (2007) 2.02
Role of iron in brain injury after intraventricular hemorrhage. Stroke (2010) 1.91
Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg (2006) 1.82
Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke (2009) 1.72
The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem (2003) 1.69
Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke (2009) 1.65
The sensitivity and specificity of electrodiagnostic testing for the clinical syndrome of lumbar spinal stenosis. Spine (Phila Pa 1976) (2005) 1.61
The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery (2003) 1.59
Electromyographic and magnetic resonance imaging to predict lumbar stenosis, low-back pain, and no back symptoms. J Bone Joint Surg Am (2007) 1.52
Pathophysiology of brain edema formation. Neurosurg Clin N Am (2002) 1.50
Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab (2006) 1.49
Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab (2010) 1.46
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J Immunol (2006) 1.44
Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. Neurosurgery (2009) 1.43
Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J Biol Chem (2009) 1.42
Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem (2006) 1.40
Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res (2002) 1.39
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol (2008) 1.38
Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke (2009) 1.36
Spinal canal size and clinical symptoms among persons diagnosed with lumbar spinal stenosis. Clin J Pain (2007) 1.36
Intracerebral hemorrhage in mice: model characterization and application for genetically modified mice. J Cereb Blood Flow Metab (2004) 1.35
Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery (2006) 1.35
Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits. Stroke (2004) 1.35
Subarachnoid hemorrhage-induced hydrocephalus in rats. Stroke (2012) 1.33
A new hippocampal model for examining intracerebral hemorrhage-related neuronal death: effects of deferoxamine on hemoglobin-induced neuronal death. Stroke (2007) 1.31
Peptide and peptide analog transport systems at the blood-CSF barrier. Adv Drug Deliv Rev (2004) 1.31
Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke (2007) 1.30
Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res (2005) 1.30
The deleterious or beneficial effects of different agents in intracerebral hemorrhage: think big, think small, or is hematoma size important? Stroke (2005) 1.24
Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia. Stroke (2010) 1.22
Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J Pharmacol Exp Ther (2005) 1.19
Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke (2011) 1.19
Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos (2007) 1.19
Short-term continuous intraparenchymal intracranial pressure monitoring in presumed idiopathic intracranial hypertension. J Neuroophthalmol (2011) 1.16
Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke (2007) 1.16
Effect of sustained-mild and transient-severe hyperglycemia on ischemia-induced blood-brain barrier opening. J Cereb Blood Flow Metab (2007) 1.15
Effects of thrombin on neurogenesis after intracerebral hemorrhage. Stroke (2008) 1.15
Autophagy after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab (2007) 1.13
Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol Pharm (2005) 1.12
Mechanisms of hydrocephalus after neonatal and adult intraventricular hemorrhage. Transl Stroke Res (2012) 1.11
Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J Neurochem (2007) 1.11
Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res (2013) 1.10
Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J Biol Chem (2002) 1.10
Intracerebral hirudin injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow. J Cereb Blood Flow Metab (2004) 1.10
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage. Stroke (2011) 1.08
Thrombin-receptor activation and thrombin-induced brain tolerance. J Cereb Blood Flow Metab (2002) 1.06
Noninvasive reflection mode photoacoustic imaging through infant skull toward imaging of neonatal brains. J Neurosci Methods (2007) 1.06
Spinal stenosis, back pain, or no symptoms at all? A masked study comparing radiologic and electrodiagnostic diagnoses to the clinical impression. Arch Phys Med Rehabil (2006) 1.06
Predictors of pain and function in persons with spinal stenosis, low back pain, and no back pain. Spine (Phila Pa 1976) (2006) 1.05
Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage. Stroke (2002) 1.05